| 2024-01-17 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 30,080 0.0124% | $0.67 | $20,244 | +61.54% | |
| 2024-01-16 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 9,304 0.0046% | $0.79 | $7,350 | +61.95% | |
| 2024-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 17,257 0.0078% | $0.85 | $14,739 | +39.46% | |
| 2024-01-11 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 11,945 0.005% | $0.84 | $9,994 | +33.35% | |
| 2023-09-01 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 2,403 0.001% | $0.78 | $1,874 | +11.39% | |
| 2023-06-27 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 2,333 0.0014% | $0.92 | $2,146 | -2.55% | |
| 2023-01-17 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 10,057 0.0065% | $1.86 | $18,686 | -47.31% | |
| 2023-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 18,763 0.0107% | $1.71 | $32,010 | -49.29% | |
| 2023-01-11 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 13,042 0.0078% | $1.75 | $22,782 | -48.1% | |
| 2023-01-04 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 5,073 0.0029% | $1.69 | $8,594 | -47.5% | |
| 2022-09-01 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 2,536 0.0016% | $1.97 | $4,993 | -31.77% | |
| 2022-06-27 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 2,562 0.0015% | $1.63 | $4,176 | -10% | |
| 2022-01-18 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 11,096 0.0074% | $3.19 | $35,416 | -40.52% | |
| 2022-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 3,046 0.002% | $3.54 | $10,795 | -46.49% | |
| 2022-01-11 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 14,362 0.0091% | $3.56 | $51,081 | -48.88% | |
| 2022-01-04 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 5,532 0.0037% | $4.06 | $22,483 | -52.08% | |
| 2021-09-01 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 2,782 0.0018% | $5.20 | $14,452 | -53.27% | |
| 2021-06-28 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 2,794 0.0018% | $4.37 | $12,210 | -19.05% | |
| 2021-01-19 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 9,879 0.0061% | $5.67 | $56,009 | -16.67% | |
| 2021-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Executive Officer | 2,707 0.0018% | $6.15 | $16,654 | -15.45% |